01349.HK
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 2.51
+0.20%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 12.38x
- P/E 2027E
- 17.53x
- P/E 2028E
- 11.01x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.03x
- Price / sales
- 3.35x
- Price / cash flow
- 13.41x
Enterprise value
- Enterprise value
- HKD 1.2B
- EV / sales
- 1.53x
- EV / EBITDA
- -10.23x
- EV / EBIT
- -7.83x
- Market cap
- HKD 2.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026